These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 31836834)
1. Response to 'Comment on: 'You have got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration'. Taylor DJ; Jones L; Binns AM; Crabb DP Eye (Lond); 2020 Oct; 34(10):1937-1938. PubMed ID: 31836834 [No Abstract] [Full Text] [Related]
2. Comment on: 'You've got dry macular degeneration, end of story: a qualitative study into the experience of living with non-neovascular age-related macular degeneration'. Gandhi JS Eye (Lond); 2020 Oct; 34(10):1935-1936. PubMed ID: 31836833 [No Abstract] [Full Text] [Related]
3. 'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration. Taylor DJ; Jones L; Binns AM; Crabb DP Eye (Lond); 2020 Mar; 34(3):461-473. PubMed ID: 31118490 [TBL] [Abstract][Full Text] [Related]
4. Age-Related Macular Degeneration: Not So Wet and Dry. Guymer RH Ophthalmol Retina; 2020 Mar; 4(3):249. PubMed ID: 32151345 [No Abstract] [Full Text] [Related]
5. Correction: 'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration. Taylor DJ; Jones L; Binns AM; Crabb DP Eye (Lond); 2020 Mar; 34(3):603. PubMed ID: 31488885 [TBL] [Abstract][Full Text] [Related]
6. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy. Amaro MH; Roller AB Arq Bras Oftalmol; 2012; 75(4):273-6. PubMed ID: 23258660 [TBL] [Abstract][Full Text] [Related]
8. Implications of the anatomical classification of the neovascular form of age-related macular degeneration. Gallego-Pinazo R; Monje-Fernández L; García-Marín N; Andreu-Fenoll M; Dolz-Marco R Arch Soc Esp Oftalmol; 2017 Feb; 92(2):71-77. PubMed ID: 27378456 [TBL] [Abstract][Full Text] [Related]
9. Update on geographic atrophy in age-related macular degeneration. Biarnés M; Monés J; Alonso J; Arias L Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519 [TBL] [Abstract][Full Text] [Related]
10. Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents. Gemenetzi M; Lotery AJ; Patel PJ Eye (Lond); 2017 Jan; 31(1):1-9. PubMed ID: 27716750 [TBL] [Abstract][Full Text] [Related]